SPY337.04+2.15 0.64%
DIA278.14+0.64 0.23%
IXIC11,326.51+159.00 1.42%

Raymond James Initiates Coverage On PTC Therapeutics with Outperform Rating, Announces Price Target of $63

Raymond James analyst Danielle Brill initiates coverage on PTC Therapeutics (NASDAQ:PTCT) with a Outperform rating and announces Price Target of $63.

Benzinga · 08/25/2020 10:36
Raymond James analyst Danielle Brill initiates coverage on PTC Therapeutics (NASDAQ: PTCT) with a Outperform rating and announces Price Target of $63.